BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31395470)

  • 1. Producing the vulnerable subject in English drug policy.
    Brown K; Wincup E
    Int J Drug Policy; 2020 Jun; 80():102525. PubMed ID: 31395470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problematisation and centralised assessment in drug treatment sector reform.
    Berends L
    Int J Drug Policy; 2020 Jun; 80():102561. PubMed ID: 31611166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Producing the 'problem' of new psychoactive substances (NPS) in English prisons.
    Duke K
    Int J Drug Policy; 2020 Jun; 80():102479. PubMed ID: 31155432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "What constitutes a 'problem'?" Producing 'alcohol problems' through online counselling encounters.
    Savic M; Ferguson N; Manning V; Bathish R; Lubman DI
    Int J Drug Policy; 2017 Aug; 46():79-89. PubMed ID: 28668695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'It's good being part of the community and doing the right thing': (Re)problematising 'community' in new recovery-oriented policy and consumer accounts.
    Fomiatti R
    Int J Drug Policy; 2020 Jun; 80():102450. PubMed ID: 31229446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Producing alcohol and other drugs as a policy 'problem': A critical analysis of South Africa's 'National Drug Master Plan' (2013-2017).
    Pienaar K; Savic M
    Int J Drug Policy; 2016 Apr; 30():35-42. PubMed ID: 26806640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining the construction and representation of drugs as a policy problem in Australia's National Drug Strategy documents 1985-2010.
    Lancaster K; Ritter A
    Int J Drug Policy; 2014 Jan; 25(1):81-7. PubMed ID: 23931957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "A spray bottle and a lollipop stick": An examination of policy prohibiting sterile injecting equipment in prison and effects on young men with injecting drug use histories.
    Walker S; Seear K; Higgs P; Stoové M; Wilson M
    Int J Drug Policy; 2020 Jun; 80():102532. PubMed ID: 31427211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laws prohibiting peer distribution of injecting equipment in Australia: A critical analysis of their effects.
    Lancaster K; Seear K; Treloar C
    Int J Drug Policy; 2015 Dec; 26(12):1198-206. PubMed ID: 26118796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Problematising LGBTIQ drug use, governing sexuality and gender: A critical analysis of LGBTIQ health policy in Australia.
    Pienaar K; Murphy DA; Race K; Lea T
    Int J Drug Policy; 2018 May; 55():187-194. PubMed ID: 29395699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing or reproducing inequalities in health? An intersectional policy analysis of how health inequalities are represented in a Swedish bill on alcohol, drugs, tobacco and gambling.
    Fagrell Trygg N; Gustafsson PE; Hurtig AK; Månsdotter A
    BMC Public Health; 2022 Jul; 22(1):1302. PubMed ID: 35794588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Making up a new drug user from depenalization to repenalisation of drug users in Denmark.
    Houborg E; Søgaard TF; Mogensen SAI
    Int J Drug Policy; 2020 Jun; 80():102660. PubMed ID: 31980294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Producing the 'problem of drugs': A cross national-comparison of 'recovery' discourse in two Australian and British reports.
    Lancaster K; Duke K; Ritter A
    Int J Drug Policy; 2015 Jul; 26(7):617-25. PubMed ID: 25962733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Undisciplined" drinking, multi-sectoralism and political power: Examining problematisations in the Botswana alcohol policy.
    Sebeelo TB
    Int J Drug Policy; 2021 Aug; 94():103228. PubMed ID: 33845411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Potential issues of morbidity, toxicity and dependence': Problematizing the up-scheduling of over-the-counter codeine in Australia.
    Weier M; Farrugia A
    Int J Drug Policy; 2020 Jun; 80():102538. PubMed ID: 31362859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Naloxone works': The politics of knowledge in 'evidence-based' drug policy.
    Lancaster K; Treloar C; Ritter A
    Health (London); 2017 May; 21(3):278-294. PubMed ID: 28135864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Governing through problems: the formulation of policy on amphetamine-type stimulants (ATS) in Australia.
    Fraser S; Moore D
    Int J Drug Policy; 2011 Nov; 22(6):498-506. PubMed ID: 22054738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'We are still obsessed by this idea of abstinence': A critical analysis of UK news media representations of proposals to introduce drug consumption rooms in Glasgow, UK.
    Atkinson AM; McAuley A; Trayner KMA; Sumnall HR
    Int J Drug Policy; 2019 Jun; 68():62-74. PubMed ID: 31003193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partnerships and communities in English drug policy: the challenge of deprivation.
    Macgregor S; Thickett A
    Int J Drug Policy; 2011 Nov; 22(6):478-90. PubMed ID: 21890338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.